Showing 921 - 940 results of 27,689 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 50 ((na decrease) OR (a decrease)) ))', query time: 1.11s Refine Results
  1. 921

    Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…Outpatient visit frequency also significantly declined from 11.5 ± 4.3 visits in the year before surgery to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g004" target="_blank">Fig 4</a>).…”
  2. 922

    Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  3. 923

    Sample means, SDs, and selected correlations. by Erik Lykke Mortensen (7239170)

    Published 2025
    “…Educational attainment was a particularly strong predictor of status attainment. …”
  4. 924

    Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  5. 925

    Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”
  6. 926
  7. 927
  8. 928
  9. 929

    Effects of riluzole on <i>I<sub>NaP</sub></i> and <i>I<sub>NaT</sub></i> in A-type neurons of the compressed DRG. by Rou-Gang Xie (179362)

    Published 2013
    “…<p>(A) Traces of <i>I<sub>NaP</sub></i> (bottom) induced by increasing applied voltage (top) in a compressed DRG neuron in the absence (control) and presence of riluzole (2, 10, 50 µM). …”
  10. 930

    Selective TASK‑1 Inhibitor with a Defined Structure–Activity Relationship Reduces Cancer Cell Proliferation and Viability by Bárbara Arévalo (4053358)

    Published 2022
    “…Mutation of seven residues to A (I118A, L122A, F125A, Q126A, L232A, I235A, and L239A) markedly decreased the F3-induced inhibition of TASK-1 channels, consistent with the molecular modeling predictions. …”
  11. 931

    Selective TASK‑1 Inhibitor with a Defined Structure–Activity Relationship Reduces Cancer Cell Proliferation and Viability by Bárbara Arévalo (4053358)

    Published 2022
    “…Mutation of seven residues to A (I118A, L122A, F125A, Q126A, L232A, I235A, and L239A) markedly decreased the F3-induced inhibition of TASK-1 channels, consistent with the molecular modeling predictions. …”
  12. 932

    Analysis of Y dLGN cells whose percentage of response in burst was less than 40–50%. by Nelson Espinosa (356237)

    Published 2013
    “…<p>rTMS@1Hz increased the percentage of spikes in burst <i>(</i><b><i>A</i></b><i>)</i> and consequently decreased tonic spikes <i>(</i><b><i>B</i></b><i>).…”
  13. 933

    The p50 Subunit of NF-κB Orchestrates Dendritic Cell Lifespan and Activation of Adaptive Immunity by Paola Larghi (131929)

    Published 2012
    “…We propose that nuclear accumulation of the p50 NF-κB subunit in DC, as occurring during lipopolysaccharide-driven maturation, is a homeostatic mechanism tuning the balance between uncontrolled activation of adaptive immunity and immune tolerance.…”
  14. 934

    Identification of Genes that Elicit Disuse Muscle Atrophy via the Transcription Factors p50 and Bcl-3 by Chia-Ling Wu (114083)

    Published 2011
    “…<em>Trim63 (MuRF1)</em>, <em>Fbxo32</em> (<em>MAFbx</em>), <em>Ubc</em>, <em>Ctsl</em>, <em>Runx1</em>, <em>Tnfrsf12a</em> (Tweak receptor), and Cxcl10 (<em>IP-10</em>) showed increased Bcl-3 binding to κB sites in unloaded muscle and thus were direct targets of Bcl-3. p50 binding to the same sites on these genes either did not change or increased, supporting the idea of p50:Bcl-3 binding complexes. p65 binding to κB sites showed decreased or no binding to these genes with unloading. …”
  15. 935

    Myosin phosphatase and RhoA-activated kinase modulate neurotransmitter release by regulating SNAP-25 of SNARE complex by Dániel Horváth (4015034)

    Published 2017
    “…Inhibition of PP1 with tautomycetin increased, whereas inhibition of ROK by H1152, decreased the phosphorylation of SNAP-25 at Thr138 in B50 cells, in cortical synaptosomes, and in brain slices. …”
  16. 936
  17. 937
  18. 938
  19. 939
  20. 940